The COA corporate members program is designed to bring together all members of the cancer care delivery system. Qualified industry companies in the biotechnology, pharmaceutical, genomic, drug delivery and distribution, and other spheres support COA’s mission to ensure that all Americans have access to high-quality, affordable, and accessible cancer care in the communities where they live and work.
Through the Corporate Members program, COA fosters and enhances communication between community oncology and industry representatives seeking to improve the cancer care delivery system. Through COA, we provide a forum for addressing common issues – not specific brand, product, or product-specific issues – that impact patient care and care delivery. Our Corporate Members program supports COA’s education work, special projects, advocacy activities, staffing and support services, and Washington, DC office.
COA maintains a strict policy of independence from corporate and commercial influences, such as those related to specific companies, products, or services. The COA Board of Directors strictly enforces this policy. Participation in the Corporate Members program does not influence any of COA’s policies, positions, or endeavors. Fundamentally, everything that COA does is driven by our mission to foster and protect the quality, affordability, and accessibility of community cancer care for all Americans.